Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 3
1995 1
1996 7
1997 2
1998 5
1999 4
2000 5
2001 5
2002 3
2003 5
2004 2
2005 4
2006 4
2007 1
2008 4
2009 4
2010 4
2011 5
2012 5
2013 1
2014 6
2015 4
2016 5
2017 4
2018 3
2019 3
2020 8
2021 4
2022 2
2023 7
2024 9
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial.
Dhondt E, Lambert B, Hermie L, Huyck L, Vanlangenhove P, Geerts A, Verhelst X, Aerts M, Vanlander A, Berrevoet F, Troisi RI, Van Vlierberghe H, Defreyne L. Dhondt E, et al. Among authors: defreyne l. Radiology. 2022 Jun;303(3):699-710. doi: 10.1148/radiol.211806. Epub 2022 Mar 8. Radiology. 2022. PMID: 35258371 Clinical Trial.
Interventional radiology for liver diseases.
Defreyne L. Defreyne L. Eur Radiol. 2021 Apr;31(4):2227-2230. doi: 10.1007/s00330-020-07356-w. Epub 2020 Oct 3. Eur Radiol. 2021. PMID: 33009937 Free PMC article. No abstract available.
REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Mayer SA, Bruder N, Citerio G, Defreyne L, Dubois C, Gupta R, Higashida R, Marr A, Nguyen TN, Roux S, Smrčka M, Torné RT, Aldrich EF; on behalf of the REACT investigators. Mayer SA, et al. Among authors: defreyne l. J Neurosurg. 2024 Aug 9;142(1):98-109. doi: 10.3171/2024.4.JNS232191. Print 2025 Jan 1. J Neurosurg. 2024. PMID: 39126720 Clinical Trial.
Hemorrhagic transformation in acute ischemic stroke: hemorrhagic subtypes and symptomatic intracranial hemorrhage.
Luff MK, Khezri N, Miralbes S, Naravetla B, Spiotta AM, Loehr C, Martínez-Galdámez M, McTaggart RA, Defreyne L, Vega P, Zaidat OO, Price LL, Gupta R, Möhlenbruch MA, Liebeskind DS; ASSIST Investigators. Luff MK, et al. Among authors: defreyne l. J Neurointerv Surg. 2024 Jul 5:jnis-2024-021725. doi: 10.1136/jnis-2024-021725. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38969497
Technique and impact on first pass effect primary results of the ASSIST global registry.
Gupta R, Miralbés S, Calleja Bonilla A, Naravetla B, Majjhoo AQ, Rayes M, Spiotta AM, Loehr C, Cioltan A, Vollherbst DF, Martínez-Galdámez M, Galván-Fernandez J, Khaldi A, McTaggart RA, Jayaraman MV, Defreyne L, Dhondt E, Vega P, Murias E, Lin E, Chaubal V, Price LL, Liebeskind DS, Möhlenbruch MA; ASSIST Investigators. Gupta R, et al. Among authors: defreyne l. J Neurointerv Surg. 2024 Jan 9:jnis-2023-021126. doi: 10.1136/jnis-2023-021126. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38195248
Hepatocellular carcinoma.
van den Bosch MA, Defreyne L. van den Bosch MA, et al. Among authors: defreyne l. Lancet. 2012 Aug 4;380(9840):469-70; author reply 470-1. doi: 10.1016/S0140-6736(12)61284-7. Lancet. 2012. PMID: 22863044 No abstract available.
Radionuclide therapy for hepatocellular carcinoma.
Lambert B, Van Vlierberghe H, Troisi R, Defreyne L. Lambert B, et al. Among authors: defreyne l. Acta Gastroenterol Belg. 2010 Oct-Dec;73(4):484-8. Acta Gastroenterol Belg. 2010. PMID: 21299159 Free article. Review.
111 results